Cargando…
Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine
Conventional anticancer therapies, such as chemo- and/or radio-therapy are often unable to completely eradicate cancers due to abnormal tumor microenvironment, as well as increased drug/radiation resistance. More effective therapeutic strategies for overcoming these obstacles are urgently in demand....
Autores principales: | Xiang, Dongxi, Shigdar, Sarah, Qiao, Greg, Wang, Tao, Kouzani, Abbas Z., Zhou, Shu-Feng, Kong, Lingxue, Li, Yong, Pu, Chunwen, Duan, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265746/ https://www.ncbi.nlm.nih.gov/pubmed/25553096 http://dx.doi.org/10.7150/thno.10202 |
Ejemplares similares
-
Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
por: Xiang, Dongxi, et al.
Publicado: (2015) -
Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation
por: Shigdar, Sarah, et al.
Publicado: (2013) -
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
por: AlShamaileh, Hadi, et al.
Publicado: (2017) -
Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
por: AlShamaileh, Hadi, et al.
Publicado: (2020) -
EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
por: Wang, Tao, et al.
Publicado: (2015)